SINTX is a spinal and orthopedic implant company using its silicon nitride ceramic tech to develop spine and total joint implants.
SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The Company presently manufactures silicon nitride spinal implants in its ISO 13485 certified manufacturing facility for CTL-Amedica, the exclusive retail channel for silicon nitride spinal implants.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 2, 2014 | Post-IPO Debt | $26M | 1 | Hercules Capital | — | Detail |
Jan 25, 2008 | Series D | $10.30M | 1 | Creation Capital | — | Detail |
May 17, 2007 | Series D | $13.20M | 1 | Creation Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hercules Capital | Yes | Post-IPO Debt |
Creation Capital | Yes | Series D |